CN Stock MarketDetailed Quotes
300149 ChemPartner PharmaTech
- 3.88
- +0.01+0.26%
Market Closed Jul 26 15:00 CST
1.94BMarket Cap-2143P/E (TTM)
3.91High3.83Low34.14KlotVolume3.86Open3.87Pre Close13.26MTurnover0.68%Turnover RatioLossP/E (Static)499.78MShares9.7452wk High1.35P/B1.94BFloat Cap3.6852wk Low4.64Limit Up498.91MShs Float28.27Historical High3.10Limit Down2.07%Amplitude2.25Historical Low--Dividend TTM3.88Avg Price18.07KlotAsk--Div YieldTTM100Lot Size14.81KlotBid
ChemPartner PharmaTech Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -3.53%331.05M | -54.41%347.26M | -58.32%294.17M | -70.01%263.29M | 461.02%343.16M | 374.67%761.66M | 121.52%705.81M | 209.67%877.9M | -79.50%61.17M | -38.08%160.46M |
| Transactional financial assets | -80.88%1.59M | --2.21M | 169.98%6.2M | 17,233.33%15.6M | 89.40%8.33M | ---- | -94.30%2.3M | -99.71%90K | -76.78%4.4M | -5.44%18.98M |
| Notes receivable and accounts receivable | -29.08%234.1M | -22.74%263.85M | -20.67%296.5M | -8.14%326M | -20.46%330.08M | 1.62%341.49M | 3.52%373.78M | -8.06%354.87M | 8.14%414.98M | -12.99%336.06M |
| -Notes receivable | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | -49.69%895.68K |
| -Accounts receivable | -29.08%234.1M | -22.74%263.85M | -20.67%296.5M | -8.14%326M | -20.46%330.08M | 1.89%341.49M | 3.63%373.78M | -7.56%354.87M | 8.43%414.98M | -12.82%335.17M |
| Other receivables (including interest and dividends) | -79.32%17.36M | -86.22%12.01M | -79.21%87.22M | -79.17%90.05M | 773.66%83.96M | 926.76%87.18M | 8,569.68%419.46M | 7,034.72%432.2M | -87.52%9.61M | -90.16%8.49M |
| -Other receivable | ---- | ---- | ---- | -79.17%90.05M | ---- | 926.76%87.18M | ---- | 7,034.72%432.2M | ---- | -90.16%8.49M |
| Contractual assets | -31.34%7.37M | -49.23%4.25M | -11.34%16.5M | -7.08%16.9M | -66.42%10.73M | -76.87%8.38M | -73.36%18.61M | -76.20%18.19M | -34.54%31.94M | -1.86%36.22M |
| Advance payment | -52.33%6.89M | -35.59%10.34M | -36.63%12.69M | 3.07%21.76M | -46.85%14.45M | -25.06%16.06M | -47.65%20.02M | -32.30%21.11M | -2.53%27.18M | -24.22%21.43M |
| Inventories | -60.91%20.83M | -34.88%27.88M | 28.45%60.53M | -15.73%37.5M | -31.25%53.3M | -37.78%42.82M | -26.74%47.12M | -20.86%44.49M | 73.05%77.52M | 25.55%68.81M |
| Receivable financing | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Non-current assets due within one year | --347.53K | --347.53K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 124.36%56.99M | 159.27%59.02M | 125.66%39.78M | 222.49%34.41M | -32.88%25.4M | -38.95%22.77M | -53.15%17.63M | -72.78%10.67M | -11.49%37.84M | -22.62%37.29M |
| Total current assets | -22.18%676.53M | -43.21%727.18M | -49.30%813.58M | -54.22%805.51M | 30.81%869.4M | 86.17%1.28B | 71.65%1.6B | 93.46%1.76B | -29.47%664.64M | -25.24%687.74M |
| Non Current assets | ||||||||||
| Other equity investment | ---- | ---- | ---- | ---- | --2.3M | ---- | ---- | ---- | ---- | ---- |
| Other non-current financial assets | --2.3M | 0.00%2.3M | --1.93M | --2.05M | ---- | --2.3M | ---- | ---- | ---- | ---- |
| Investment real estate | 491.62%78.1M | 458.42%79.21M | 73.12%27.45M | 38.51%22.28M | -72.35%13.2M | -71.55%14.19M | -68.97%15.86M | -69.79%16.09M | -9.85%47.75M | -6.94%49.86M |
| Long-term equity investment | -9.22%199.33M | 0.24%197.49M | 15.40%231.76M | 21.11%230.71M | 24.72%219.57M | 11.97%197.02M | 17.25%200.83M | 11.63%190.5M | 4.11%176.05M | 14.83%175.96M |
| Fixed assets | ---- | ---- | ---- | -2.66%489.48M | ---- | -44.19%374.54M | ---- | -27.93%502.86M | ---- | 5.29%671.08M |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
| Constru in process | ---- | ---- | ---- | -70.15%54.68M | ---- | -68.03%75.36M | ---- | 20.75%183.19M | ---- | -23.66%235.74M |
| Intangible assets | -43.27%31.16M | -46.01%30.05M | -21.59%49.36M | -18.32%54.38M | -61.70%54.92M | -62.55%55.66M | -58.59%62.95M | -57.13%66.58M | -10.24%143.38M | -9.93%148.61M |
| Goodwill | -80.90%164.03M | -80.90%164.03M | -21.07%858.86M | -21.07%858.86M | -28.87%858.86M | -28.87%858.86M | -30.91%1.09B | -30.91%1.09B | -23.34%1.21B | -23.34%1.21B |
| Long deferred expense | -12.86%313.92M | -12.39%324.36M | -4.07%353.89M | -1.47%355.21M | -4.16%360.26M | -3.84%370.23M | -4.71%368.92M | -12.75%360.51M | 38.09%375.89M | 36.63%385.02M |
| Deferred tax assets | 134.20%40.06M | 279.33%40.45M | -49.17%9.75M | -28.60%10.91M | -0.56%17.11M | 118.17%10.66M | -39.84%19.18M | -39.09%15.29M | -25.43%17.2M | -62.69%4.89M |
| Usufruct assets | -10.71%450.16M | -10.35%469.49M | -11.25%483.16M | -10.71%503.13M | -13.50%504.15M | -13.39%523.72M | -3.79%544.43M | 3.41%563.5M | 2.67%582.82M | --604.71M |
| Other non current assets | 2.74%41.43M | -30.11%42.64M | -64.26%34.19M | -46.21%43.55M | -40.68%40.33M | 31.12%61.01M | 84.49%95.68M | 82.66%80.97M | 215.63%67.98M | 237.10%46.53M |
| Total non current assets | -35.15%1.69B | -31.91%1.73B | -16.20%2.6B | -14.42%2.63B | -26.41%2.61B | -27.94%2.54B | -20.21%3.1B | -19.93%3.07B | -7.27%3.55B | 10.25%3.53B |
| Total assets | -31.92%2.37B | -35.69%2.46B | -27.49%3.41B | -28.93%3.43B | -17.39%3.48B | -9.33%3.82B | -2.39%4.7B | 1.82%4.83B | -11.65%4.22B | 2.33%4.22B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -32.33%64.3M | -47.83%60M | -60.00%60M | -40.00%60M | -40.54%95.02M | -27.46%115.02M | -34.67%150M | -20.19%100M | 30.47%159.82M | 40.95%158.57M |
| Notes payable and accounts payable | -59.57%35.81M | -33.34%53.79M | -39.38%56.07M | -41.37%55.83M | -31.25%88.56M | -25.54%80.7M | -37.72%92.5M | -42.83%95.21M | -7.65%128.82M | 35.19%108.38M |
| -Notes payable | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| -Accounts payable | -59.57%35.81M | -33.34%53.79M | -39.38%56.07M | -41.37%55.83M | -31.25%88.56M | -25.54%80.7M | -14.76%92.5M | -24.76%95.21M | 29.48%128.82M | 40.32%108.38M |
| Contract liabilities | -28.95%60.08M | -1.67%73.24M | 85.34%99.7M | 67.36%96.15M | 32.22%84.56M | 34.71%74.48M | -35.33%53.79M | -17.13%57.45M | -5.32%63.96M | -5.47%55.29M |
| Salaries payable | 102.71%61.92M | -13.79%57.62M | 30.77%50.31M | 40.80%41.78M | -42.66%30.55M | 12.38%66.84M | -21.49%38.47M | -23.44%29.68M | 59.49%53.27M | 59.49%59.47M |
| Taxs payable | -78.02%3.95M | -83.63%8.46M | -96.57%6.51M | -98.74%4.83M | -21.41%17.97M | 246.97%51.7M | 1,400.30%189.69M | 3,588.33%382.86M | 1,349.06%22.86M | 81.02%14.9M |
| Other payable (including interest and dividends) | -51.78%84.77M | -39.29%98.71M | -13.62%159.17M | -23.54%150.51M | -23.95%175.81M | -13.03%162.59M | -19.51%184.27M | -16.70%196.84M | -5.91%231.17M | -25.60%186.94M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -81.38%149.82K | ---- | ---- |
| -Other payable | ---- | ---- | ---- | -23.48%150.51M | ---- | -13.03%162.59M | ---- | -16.47%196.69M | ---- | --186.94M |
| Non current liabilities due within one year | -21.44%73.67M | -58.63%73.93M | -61.15%70.19M | -61.64%78.84M | -75.55%93.77M | -55.65%178.71M | -54.98%180.66M | -36.61%205.51M | 68.70%383.47M | 71.60%402.96M |
| Other current liabilities | -80.75%431.05K | -48.84%1.02M | 2.75%1.36M | -69.96%1.96M | -43.26%2.24M | -51.84%2M | -27.68%1.32M | 477.03%6.52M | 59.13%3.95M | -14.14%4.14M |
| Total current liabilities | -34.59%384.93M | -41.70%426.77M | -43.49%503.31M | -54.39%489.9M | -43.81%588.48M | -26.11%732.03M | -22.88%890.71M | 10.51%1.07B | 24.68%1.05B | 25.78%990.66M |
| Current liabilities | ||||||||||
| Long term loan | 126.52%43.67M | -75.35%43.67M | -78.91%47.08M | -81.99%41.02M | -96.62%19.28M | -71.18%177.21M | -67.74%223.27M | -71.69%227.73M | -32.76%570.94M | -22.37%614.92M |
| Estimate liabilities | 4.35%5.3M | 4.35%5.24M | 4.35%5.19M | 4.47%5.13M | 4.35%5.08M | 4.35%5.02M | 5.09%4.97M | 4.23%4.91M | 4.35%4.87M | 4.20%4.81M |
| Deferred tax liabilities | 4.82%10.31M | 4.78%12.58M | -23.67%9.89M | 16.13%13.11M | -56.28%9.84M | -53.95%12.01M | -12.82%12.96M | -27.77%11.29M | -12.59%22.5M | -22.02%26.07M |
| Long term deferred income | 63.65%26.49M | 67.17%27.43M | 2.16%17.04M | -5.64%15.84M | -18.38%16.19M | -19.85%16.41M | -21.24%16.68M | -21.41%16.79M | -3.50%19.83M | -9.19%20.47M |
| Lease liabilities | -10.87%438.45M | -7.58%457.73M | -8.74%474M | -8.75%491.87M | -11.62%491.91M | -13.20%495.25M | 0.01%519.39M | 8.92%539.04M | -3.05%556.59M | --570.58M |
| Other non current liabilities | ---- | ---- | ---- | --0 | ---- | ---- | --0 | -96.15%1M | -96.15%1M | -96.15%1M |
| Total non current liabilities | -3.33%524.22M | -22.56%546.66M | -28.83%553.2M | -29.20%566.97M | -53.88%542.29M | -42.97%705.9M | -38.00%777.28M | -41.49%800.76M | -21.71%1.18B | 40.41%1.24B |
| Total liabilities | -19.60%909.15M | -32.30%973.44M | -36.66%1.06B | -43.63%1.06B | -49.13%1.13B | -35.48%1.44B | -30.75%1.67B | -19.90%1.87B | -5.07%2.22B | 33.51%2.23B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M | 0.00%499.78M |
| Other equity instruments | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Capital reserve funds | 0.00%1.23B | 0.00%1.23B | 0.00%1.23B | 0.00%1.23B | -0.00%1.23B | 0.00%1.23B | -0.01%1.23B | 0.00%1.23B | 0.00%1.23B | 0.00%1.23B |
| Surplus reserve funds | 0.00%169.65M | 0.00%169.65M | 193.04%169.65M | 193.04%169.65M | 193.04%169.65M | 193.04%169.65M | -0.17%57.89M | -0.17%57.89M | 0.00%57.89M | 0.00%57.89M |
| Retained profit | -201.05%-454.79M | -189.70%-429.33M | -64.59%437.41M | -60.90%456.84M | 103.40%450.05M | 125.99%478.62M | 96.41%1.24B | 88.70%1.17B | -65.99%221.26M | -67.37%211.79M |
| Less:Treasury stock | 0.00%25.51M | 0.00%25.51M | 0.00%25.51M | 0.00%25.51M | 0.00%25.51M | 24.77%25.51M | 24.77%25.51M | 24.77%25.51M | 24.77%25.51M | --20.44M |
| Other composite income | 343.62%19.51M | 79.72%17.64M | 28.18%19.81M | 1,108.46%19.6M | 130.09%4.4M | 171.33%9.81M | 278.87%15.46M | 80.33%-1.94M | -26.65%-14.62M | -72.60%-13.76M |
| Shareholders equity without minority interests | -38.23%1.44B | -38.12%1.46B | -22.63%2.33B | -19.75%2.35B | 18.27%2.33B | 20.21%2.36B | 26.19%3.01B | 23.23%2.93B | -18.19%1.97B | -19.09%1.96B |
| Minority interests | -0.81%24.2M | -0.76%24.24M | -0.77%24.28M | -0.93%24.36M | -0.74%24.4M | -0.84%24.43M | 0.50%24.47M | 1.02%24.59M | 0.57%24.58M | 0.61%24.63M |
| Total shareholder equity | -37.84%1.46B | -37.73%1.49B | -22.46%2.35B | -19.59%2.37B | 18.04%2.35B | 19.95%2.39B | 25.93%3.04B | 23.01%2.95B | -18.00%1.99B | -18.89%1.99B |
| Total liabilityies and equity | -31.92%2.37B | -35.69%2.46B | -27.49%3.41B | -28.93%3.43B | -17.39%3.48B | -9.33%3.82B | -2.39%4.7B | 1.82%4.83B | -11.65%4.22B | 2.33%4.22B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg